This site is intended for Healthcare Professionals only

Congratulations on completing this module  (0% complete)

quiz close icon

module menu icon Pepto-Bismol oral suspension

PEPTO-BISMOL ORAL SUSPENSION

RECOMMENDING PEPTO-BISMOL ORAL SUSPENSION7

Pepto-Bismol can be used by adults and adolescents 16 years old and over for the symptomatic relief of heartburn, indigestion, nausea and upset stomach as well as to control diarrhoea.

30ml of the oral solution should be taken using the dosing cup provided. This can be repeated every half hour to 1 hour if needed, with no more than 8 doses to be taken in 24 hours. Advise customers to shake the bottle before use.

ABOUT PEPTO-BISMOL

Click through the carousel for more information.

WHO SHOULD NOT USE IT7

  • Pepto-Bismol contains salicylates and therefore patients taking certain medicines shouldn’t take it without consulting their doctor. These include anti-coagulant medicines (blood thinners), medicines for gout and arthiritis, and sulfonylurea medicines for diabetes

  • Pepto-Bismol should not be used during pregnancy and breastfeeding

  • Pepto-Bismol is not suitable for children under 16 years of age

  • Pepto-Bismol should not be used if patients are allergic to aspirin or other salicylates, or if they are taking aspirin or other salicylates currently

  • Patients with a peptic ulcer or blood clotting disorders should not take Pepto-Bismol

SIDE EFFECTS7

Pepto-Bismol can cause the surface of the tongue and stools to blacken. This is short-lived and resolves when Pepto-Bismol is stopped but can be concerning to patients. It also contains the colouring amaranth (E 123) which may cause allergic type reactions including asthma.

See more information on how to report adverse reactions at the end of the module.

COUNSELLING POINTS FOR PATIENTS6,7

  • Pepto-Bismol can be taken before or after meals, on either an empty or full stomach

  • Make sure to stay hydrated using fluid and electrolyte replacement therapy, if appropriate

WHEN TO REFER6,7

  • Symptoms lasting more than two days should be referred to the pharmacist or doctor for further investigation

  • Any red flag symptoms (e.g. blood or mucus in faeces) should be referred to the pharmacist or doctor

CUSTOMER SCENARIOS

Consider how you would support these patients

A pregnant woman is complaining of heartburn and indigestion symptoms. She is otherwise well and isn’t taking any other medicines. Her pregnancy has been straightforward aside from nausea during the first trimester which has subsided. She asks for Pepto-Bismol as it effectively managed her symptoms prior to her pregnancy.

WHICH OF THE FOLLOWING OPTIONS WOULD BE MOST APPROPRIATE TO RECOMMEND?

Recommend Pepto-Bismol to the customer

INCORRECTPepto-Bismol is not suitable for people who are pregnant

Provide her with advice to help prevent symptoms such as eating small meals, not eating too close to bedtime and avoiding food and drinks that trigger symptoms such as spicy food, fatty foods, fizzy drinks.

CORRECT

Refer the customer to their GP for further investigation

INCORRECTWhile the GP may recommend some management options for the heartburn, self-care advice and other product suggestions can be given to help the customer first


A 45-year-old man asks for something that can treat his symptoms. He has had heartburn, indigestion, an upset stomach, nausea and diarrhoea after overindulging at lunch at a work networking event. He wants the convenience of only taking one product to manage all his symptoms.

WHICH OF THE FOLLOWING OPTIONS WOULD BE MOST APPROPRIATE?

Recommend Pepto-Bismol to the customer

CORRECTPepto-Bismol can be used to manage all 5 of the patient’s symptoms

Recommend a PPI to the customer

INCORRECTWhile this would manage some symptoms it wouldn’t manage the nausea and diarrhoea

Refer the patient to the GP

INCORRECTThe customer’s symptoms could be managed over the counter rather than having to wait to see a GP


A 20-year-old female requests something to help with the indigestion she’s been experiencing over the last few weeks. Her appetite has dropped off and she’s noticed she’s lost some weight.

WHICH OF THE FOLLOWING OPTIONS WOULD BE MOST APPROPRIATE?

Recommend an antacid to manage symptoms

INCORRECTThe customer has red flag symptoms and needs referral

Recommend Pepto-Bismol to manage symptoms

INCORRECTThe customer has red flag symptoms and needs referral

Refer the customer to their GP for further investigation

CORRECTThe customer has red flag symptoms that need further investigation by the GP

References

1.P&G data on file, n=2000

2.NHS. Heartburn and acid reflux. 2023. Available at: www.nhs.uk/conditions/heartburn-and-acid-reflux/

3.NHS. Indigestion. 2023. Available at: www.nhs.uk/conditions/indigestion/

4.NHS. Feeling sick (nausea). 2023. Available at: www.nhs.uk/conditions/feeling-sick-nausea/

5.NHS. Diarrhoea and vomiting. 2023. Available at: www.nhs.uk/conditions/diarrhoea-and-vomiting/

6.NHS. About Pepto-Bismol. 2022 Available at: www.nhs.uk/medicines/pepto-bismol/about-pepto-bismol/

7. Summary of Product Characteristics. Pepto-Bismol 17.5mg/mL oral solution.2023.
Available at: https://mhraproducts4853.blob.core.windows.net/docs/64a487d27c6660c75e6ba370a49398fca93bb2a6

8. Vincent P. Indigestion. Patient.info. 2023. Available at: https://patient.info/digestive-health/dyspepsia-indigestion#preventing-indigestion

Online references last accessed January 2025

Essential information

Pepto-Bismol 17.5 mg/ml Oral Suspension. Active ingredient: Each ml of suspension contains 17.5 mg Bismuth Subsalicylate. One dose of 30 ml dose contains 525 mg Bismuth Subsalicylate. Indicated in adults and adolescents aged 16 years and over for symptomatic relief of heartburn, indigestion, nausea and upset stomach (due to overindulgence in food and drink). Also controls diarrhoea. MAH: Procter & Gamble (Health & Beauty Care) Ltd. The Heights, Brooklands, Weybridge. Surrey, KT13 0XP, UK. Supply classification: GSL. Information about this product, including adverse reactions, precautions, contraindications, and method of use can be found at: https://mhraproducts4853.blob.core.windows.net/docs/ebb4634d80d1c1392377900d4bd5ede4228124b3

If users experience any side effects, they should discontinue use and seek pr ofessional medical advice.
To report any potential side effects, contact us or use the MHRA’s Yellow Card Scheme available at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store.

Change privacy settings